Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) EBIAT (2016 - 2026)

Cryo Cell International's EBIAT history spans 17 years, with the latest figure at $47108.0 for Q1 2026.

  • Quarterly results put EBIAT at $47108.0 for Q1 2026, down 83.35% from a year ago — trailing twelve months through Feb 2026 was -$2.7 million (down 2170.66% YoY), and the annual figure for FY2025 was -$2.4 million, down 704.18%.
  • EBIAT for Q1 2026 was $47108.0 at Cryo Cell International, up from -$3.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $1.1 million in Q3 2024 to a low of -$11.2 million in Q4 2023.
  • The 5-year median for EBIAT is $556241.0 (2024), against an average of -$513555.5.
  • The sharpest move saw EBIAT skyrocketed 231.49% in 2022, then crashed 1435.61% in 2023.
  • Year by year, EBIAT stood at $837822.0 in 2022, then crashed by 1435.61% to -$11.2 million in 2023, then surged by 83.36% to -$1.9 million in 2024, then crashed by 105.06% to -$3.8 million in 2025, then soared by 101.23% to $47108.0 in 2026.
  • According to Business Quant data, EBIAT over the past three periods came in at $47108.0, -$3.8 million, and $749408.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.